Connect to other sites within the UBM Medica Network
Biomarkers Delineate 3 Distinct Psychosis Biotypes
Brain-based biomarkers identify more biologically homogeneous categories of psychosis than do clinical diagnoses.
Practice Patterns for ADHD and Other Disorders Collide
Recent data show that widespread discrepancy exists between clinical guidelines and practice patterns for ADHD, dementia, and bipolar disorders.
Top-down Plus Bottom-up Integrative Treatments in Psychiatry
Top-down approaches, in which the mind of the therapist engages the mind of the patient, have dominated traditional psychotherapy and psychoanalysis.
What’s With These Names in Mental Health Care?
Recently, there were two reports about concerns over changes in terminology in our field. So, what's in a name?
Antipsychotic Rechallenge After an Adverse Event
Are you up-to-date on the risk of recurrent pneumonia in patients with schizophrenia when an antipsychotic is reintroduced?
Hype, Hope, and Hard Work Ahead
A podcast on new digital technologies for psychiatry.
Meditation, Managed Care, and Mental Health
In recent years, health care insurance companies (and the businesses that use them) have begun to invest in mindfulness research and programs What has happened to explain this development?
Psychiatry Roundup: January
Editors' picks, including the biggest story of the year thus far and others of interest to psychiatrists and the public.
Depression Research Update: February 2016
Three new studies show the effects of depression—and its treatment—on the brain.
Novel Route for Ketamine in the Treatment of MDD
This method of administration can mitigate the psychotomimetic and dissociative effects of ketamine.
By clicking Accept, you agree to become a member of the UBM Medica Community.